Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 1/2005

01-01-2005 | Original article

Mouse models in skeletal physiology and osteoporosis: experiences and data on 14839 cases from the Hamburg Mouse Archives

Authors: Pia Pogoda, Matthias Priemel, Arndt F. Schilling, Matthias Gebauer, Philip Catalá-Lehnenf, Florian Barvencik, F. Timo Beil, Christian Münch, Martin Rupprecht, Cordula Müldner, Johannes M. Rueger, Thorsten Schinke, Michael Amling, P. Pogoda, M. Priemel, A. F. Schilling, M. Gebauer, P. Catalá-Lehnen, F. Barvencik, F. T. Beil, C. Munch, M. Rupprecht, C. Miildner, J. M. Rueger, T. Schinke, M. Amling

Published in: Journal of Bone and Mineral Metabolism | Special Issue 1/2005

Login to get access
Metadata
Title
Mouse models in skeletal physiology and osteoporosis: experiences and data on 14839 cases from the Hamburg Mouse Archives
Authors
Pia Pogoda
Matthias Priemel
Arndt F. Schilling
Matthias Gebauer
Philip Catalá-Lehnenf
Florian Barvencik
F. Timo Beil
Christian Münch
Martin Rupprecht
Cordula Müldner
Johannes M. Rueger
Thorsten Schinke
Michael Amling
P. Pogoda
M. Priemel
A. F. Schilling
M. Gebauer
P. Catalá-Lehnen
F. Barvencik
F. T. Beil
C. Munch
M. Rupprecht
C. Miildner
J. M. Rueger
T. Schinke
M. Amling
Publication date
01-01-2005
Publisher
Springer-Verlag
Published in
Journal of Bone and Mineral Metabolism / Issue Special Issue 1/2005
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/BF03026332

Other articles of this Special Issue 1/2005

Journal of Bone and Mineral Metabolism 1/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine